Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05323357

Bern Human Organoid-Study to Study Host-microbe Interaction

Establishment of Human Organoid Lines as a Tool to Dissect Molecular Pathways of Host-microbiota Interactions

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The human body inhabits a complex consortium of different microbes which together form the microbiota. Virtually every surface of the human body is colonized by a distinct microbiota, forming complex communities. An increasing number of research results indicates that changes in the microbiota can have vast effects on the health of its host. Most studies investigating the microbiota were conducted on animals, as many interventions and investigations cannot be performed on humans due to ethical considerations. This raises the question if findings from experimental studies are translational and can benefit patients. That becomes especially apparent when trying to dissect molecular mechanisms involved in this fine-tuned interplay between nutrients, the microbiota, and its host. By establishing human organoid cultures from the large and small intestine that can be exposed to microbes and/or microbial products with subsequent transcriptomic, epigenetic and immunological analysis, the investigators aim to generate findings with high translational potential with new insights into the complex interaction of the microbiota, the host and its immune system.

Detailed description

* Data obtained from participants will be recorded in the database Redcap to ensure high-quality data recording * Establishment of human organoid cultures are standardized by published protocols (Pleguezuelos-Manzano et al. 2020)

Conditions

Timeline

Start date
2022-03-31
Primary completion
2025-03-30
Completion
2026-03-30
First posted
2022-04-12
Last updated
2024-12-11

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05323357. Inclusion in this directory is not an endorsement.